On the other hand, in mouse models of psoriasis, vascular inflammation, evaluated through the measure of circulating inflammatory cytokines and chemokines, and vascular dysfunction, analyzed ex-vivo by vascular responsiveness to vasodilators, were correlated with the severity of skin lesions and levels of IL-17A. This evidence concerns the gene IL17A and psoriasis.